- Home
- NTRP vs PMN Comparison
NTRP vs PMN Comparison
Compare NTRP & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRP
- PMN
- Stock Information
- Founded
- NTRP 1985
- PMN 2004
- Country
- NTRP United States
- PMN Canada
- Employees
- NTRP N/A
- PMN N/A
- Industry
- NTRP
- PMN Pharmaceuticals and Biotechnology
- Sector
- NTRP
- PMN Health Care
- Exchange
- NTRP NYSE
- PMN Nasdaq
- Market Cap
- NTRP 18.1M
- PMN 18.8M
- IPO Year
- NTRP N/A
- PMN N/A
- Fundamental
- Price
- NTRP $2.26
- PMN $0.59
- Analyst Decision
- NTRP Hold
- PMN Strong Buy
- Analyst Count
- NTRP 1
- PMN 1
- Target Price
- NTRP $5.00
- PMN $6.00
- AVG Volume (30 Days)
- NTRP 55.0K
- PMN 38.1K
- Earning Date
- NTRP 05-06-2025
- PMN 05-13-2025
- Dividend Yield
- NTRP N/A
- PMN N/A
- EPS Growth
- NTRP N/A
- PMN N/A
- EPS
- NTRP N/A
- PMN 0.11
- Revenue
- NTRP $623,664.00
- PMN N/A
- Revenue This Year
- NTRP $354.28
- PMN N/A
- Revenue Next Year
- NTRP $536.37
- PMN N/A
- P/E Ratio
- NTRP N/A
- PMN $5.23
- Revenue Growth
- NTRP 186.93
- PMN N/A
- 52 Week Low
- NTRP $1.39
- PMN $0.51
- 52 Week High
- NTRP $8.50
- PMN $2.37
- Technical
- Relative Strength Index (RSI)
- NTRP 28.73
- PMN 44.14
- Support Level
- NTRP $2.41
- PMN $0.51
- Resistance Level
- NTRP $3.28
- PMN $0.65
- Average True Range (ATR)
- NTRP 0.75
- PMN 0.08
- MACD
- NTRP -0.24
- PMN 0.01
- Stochastic Oscillator
- NTRP 3.20
- PMN 32.67
About NTRP NEXTTRIP INC
NextTrip Inc is a technology-driven platform delivering travel booking and travel media solutions. It provides individual and group travelers with vacations to popular and sought-after destinations in Mexico, the Caribbean, and across the world. NextTrip Media platform - Travel Magazine offers a social media platform for viewers to explore, educate, and share with friends their bucket list travel. The company is also launching an end-to-end content ecosystem that uses AI-assisted travel planning capturing advertising, building brand awareness, rewarding loyalty, and driving bookings.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.